Neogen Corporation Payments of Financing Costs
Neogen Corporation (NEOG) reported Payments of Financing Costs of $19.28 million for the 9-month period ending 2023-02-28, per its 10-Q filed 2023-04-04.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfFinancingCosts · last filed 2023-04-04
- Neogen Corporation payments of financing costs for the quarter ending 2023-02-28 was $0.00.
- Neogen Corporation payments of financing costs for the quarter ending 2022-02-28 was $0.00.
| Period end | Payments of Financing Costs 3 month | Payments of Financing Costs 6 month | Payments of Financing Costs 9 month |
|---|---|---|---|
| 2023-02-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-04-04 | $19.28M 10-Q · filed 2023-04-04 | |
| 2022-11-30 | $19.28M 10-Q · filed 2023-01-09 | ||
| 2022-02-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-04-04 | $0.00 10-Q · filed 2023-04-04 | |
| 2021-11-30 | $0.00 10-Q · filed 2023-01-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |